… patients after kidney transplantation based … CYP3A5 genotype data were not available. A
French study demonstrated that ethnic origin did not affect outcome after renal transplantation …

… suggest that CYP3A5 genotyping is likely more useful if available before kidney transplant.
… recipients similarly demonstrated no relationship between CYP3A5 genotype and renal …

… nor excluded an effect of the CYP3A5 genotype on the risk of … , the anticipated risk among
CYP3A5 genotype expressers is 7 … among patients with the CYP3A5 expresser genotype (OR=…

… the impact of CYP3A5, ABCB1, and ABCC2 genotypes on the dose requirement and
pharmacokinetics of tacrolimus and sirolimus in stable kidney transplant patients receiving trough-…

… based on an individual’s CYP3A5 genotype did not lead to a … kidney transplantation , as
compared to a standard, body‐weight‐based dosing approach. In addition, CYP3A5 genotype‐…

… In a recent study by our group, adult kidney transplant recipients who possessed an NR1I2
8055T allele (rs2276707) had higher tacrolimus dose–adjusted exposure compared with …

… As tacrolimus is a substrate of the CYP3A5 gene, the … CYP3A5 polymorphisms on TAC
pharmacokinetics and pharmacodynamics over time in a population of teenage kidney transplant …

… phase throughout the post–kidney transplantation period. The remaining 35 … kidney transplant
recipients in this study of personalized tacrolimus doses determined by cyp3a5 genotype …

… to assess the effect of CYP3A5 genotype on (weight-adjusted… of acute rejection after kidney
transplantation. In contrast to … kidney transplant recipients carrying at least one CYP3A5*1 …

… CYP3A5 genotyping might be useful to guide tacrolimus and sirolimus dosing. The aim of
this study was to assess the influence of CYP3A5 … evidence that CYP3A5 genotyping cannot …